Brain Research UK Miriam Marks Fellowship
The Brain Research UK Miriam Marks Fellowships were established in 2020 in partnership with UCL Queen Square Institute of Neurology. The scheme is funded by the Miriam Marks Endowment Fund, which was established by the family of Mrs Miriam Marks in 1971 to support research into brain degeneration.
This award to Dr Chris Black was one of two Fellowships awarded in 2023, and supported his research into motor neuron disease.
About Dr Chris Black
Chris has a PhD in Biomedical Engineering from Brown University in the US, where he initially remained as a post-doc carrying out research focused on the neural mechanisms of pain.
Chris then brought this engineering and neuroscience background to the study of neurodegenerative diseases. His overarching scientific goal is to combine engineering, neuroscience, and computational approaches to elucidate the brain mechanisms underlying neurodegenerative disease and neurological dysfunction, to advance diagnosis and therapy.
This fellowship enabled Chris to pursue this line of research under the supervision of Professor Rob Brownstone, whose laboratory at UCL is at the forefront of motor neuroscience, and utilises state-of-the-art techniques to investigate the neural and behavioural characteristics associated with neurodegeneration.
About ALS
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is a fatal, rapidly-progressing disease that attacks motor neurons, the nerves in the spinal cord and brain that control muscle activity, including the muscles responsible for breathing, swallowing, speaking, walking and gripping. As these nerves are attacked, messages gradually stop reaching the muscles. This initially leads to weakening and wasting and then, eventually, severe paralysis and breathing difficulties.
There is no cure for ALS; it is always fatal. There are treatments available that can extend life expectancy and improve quality of life, but by the time the disease is typically diagnosed, it has already caused significant and irreversible damage.
Delayed diagnoses are due to a lack of well-defined behavioural and biological markers of early-stage neurodegeneration. Chris’s research aimed to address this.
Identifying early disease markers of ALS
In his PhD research, Chris focused on understanding how sensory areas of the brain process information during chronic pain. He then realised that similar changes in many of the neural circuits within this region of the brain during chronic pain were implicated in motor areas of the brain during ALS. These are the ‘motor’ circuits that enable us to control movement voluntarily. Although these circuits have been well-studied, little is known about what happens to them in the long-term in the context of neurological disease. This is important in the context of ALS, as there is a need to act as quickly as possible to slow the damage.
Patients with ALS often experience a delay between the onset of symptoms and diagnosis. Chris wanted to establish whether there is any way to identify the abnormal activity in neural circuits early on, before symptoms present, with the aim of then being able to use this information to develop neurological biomarkers that can be used to diagnose ALS earlier than is currently possible.
Using mouse models, Chris first developed a new way to quantitatively capture naturalistic, whole-body coordinated movement, and then built an ‘anomaly detection pipeline’ using deep-learning models to identify neural activity associated with complex motor control and disease progression. He also recorded the electrical activity of individual motor cortex neurons in healthy mice during freely-moving climbing and found that, unexpectedly, many brain cells responded to movements of several different limbs, indicating that the cortex represents whole-body movement in a shared and distributed manner. This in turn suggests that, in ALS, coordination may break down not only because individual limbs weaken, but also because the brain’s ability to integrate information across the body to establish coordinated movement is disrupted.
Finally, Chris used a computer model of the human neocortex to show that removing inhibition from cortical circuitry makes a key class of cortical output cells over-excitable, which matches what has been measured in ALS patients using non-invasive brain stimulation and imaging techniques.
Impact
Although there is currently no cure for ALS, there are treatments that can improve life expectancy and quality of life. It is vital that these treatments are started as early as possible.
Taken together, the results of Chris’s Fellowship suggest that complex, coordinated movement serves as a viable proxy for identifying early onset features of ALS progression and that neural activity in the primary motor cortex is tied to these movements and therefore may underpin early onset and progressive loss of motor function during neurodegeneration. As such, Chris’s work can be used to help promote new methods to evaluate patients with ALS (and other conditions) and to identify potential avenues for early therapeutic intervention.
Chris says:
“I am grateful to Brain Research UK for supporting this fellowship. The award allowed me to pursue a methodologically ambitious approach; building a new behavioural assay and analysis stack from first principles rather than adopting existing coarse measures, and testing a unique, and exiting set of hypotheses. While this work carried real risk, it ultimately produced a published methodological approach and finding surrounding adaptive motor control; a novel pre-symptomatic finding; and tools whose value extends well beyond this project.”
Key publication
Christopher J Black, Marco Beato, Liam E Browne, Robert M Brownstone, Stephanie C Koch (2026). Naturalistic climbing reveals adaptive strategies for interlimb coordination in freely moving mice iScience. 2026 Apr 25;29(6):115901. doi: 10.1016/j.isci.2026.115901.